bpc157 ghk cu kpv tb500 KPV/BPC-157/TB-500/GHK-Cu (10/10/10/50 MG) KLOW: KPV, GHK-Cu, TB-500, and

None of this is a clinical safety warning

HPLC Percentage Equals Clinical Quality Chromatographic area purity does not establish identity, sterility, formulation quality or suitability for administration

Research protocols typically start at 2550mg daily for tolerance assessment, then escalate to 50100mg based on individual response and objective metabolic markers

Note: If you currently have a diagnosis of peripheral neuropathy but are unaware of your vitamin B12 levels, talk to your doctor about having your levels checked

Home Products Pharmaceutical Injections Iron Sucrose 20 mg injection Price 48000.0 INR/ Box MOQ : 5000 Boxes Iron Sucrose 20 mg injection Specification Shelf Life 24 months from manufacturing date Therapeutic Class Haematinic Prescription Status Prescription required Contraindications Known hypersensitivity to Iron Sucrose or any excipients Brand Name Iron Sucrose Injection Route of Administration Intravenous (IV) Osmolarity ~1250 mOsm/kg Indications Iron deficiency in chronic kidney disease, other iron deficiency states Composition Each 2 ml contains Iron Sucrose equivalent to 20 mg elemental iron Strength 20 mg/2 ml Dosage Form Parenteral Form Injection Safety Information Not for intramuscular or subcutaneous use Storage Conditions Store below 25C, protected from light Packaging 2 ml ampoule Generic Name Iron Sucrose pH Range 10.5 to 11.5 Usage/Application Used in treatment of iron deficiency anemia Iron Sucrose 20 mg injection Trade Information Minimum Order Quantity 5000 Boxes Supply Ability 10000 Boxes Per Month Delivery Time 7 Days About Iron Sucrose 20 mg injection Iron Sucrose 20 mg injection is a medication primarily used to treat iron deficiency anemia in patients who are unable to get sufficient iron through oral supplementation or those who have chronic kidney disease requiring dialysis